Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 22 (7) , 1178-1182
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)European Journal of Cancer, 2013
- Fertility-Sparing Therapy in Young Women With Endometrial CancerInternational Journal of Gynecological Cancer, 2010
- Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young womenAnnals of Oncology, 2010
- Conservative surgical management of stage IA endometrial carcinoma for fertility preservationFertility and Sterility, 2010
- Sparing fertility in young patients with endometrial cancerGynecologic Oncology, 2008
- Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young WomenJournal of Clinical Oncology, 2007
- Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resectionInternational Journal of Gynecological Cancer, 2005
- Risk Factors for Young Premenopausal Women With Endometrial CancerObstetrics & Gynecology, 2005
- Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature reviewGynecologic Oncology, 2004
- Fertility‐preserving treatment in young patients with endometrial adenocarcinomaCancer, 2002